Stay updated on EPOPEX Follow-up: DBV712 in Young Children Clinical Trial
Sign up to get notified when there's something new on the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page.

Latest updates to the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

- Check32 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed; no other substantive changes to core content, pricing, stock, or time slots were detected.SummaryDifference0.3%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

- Check61 days agoChange DetectedThe web page has been updated to include a new facility name and location in Washington D.C., along with a significant list of publications related to peanut allergy research. The previous location details have been removed.SummaryDifference24%

- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to EPOPEX Follow-up: DBV712 in Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page.